- Home
- CCO vs MDXG Comparison
CCO vs MDXG Comparison
Compare CCO & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCO
- MDXG
- Stock Information
- Founded
- CCO 1995
- MDXG 2006
- Country
- CCO United States
- MDXG United States
- Employees
- CCO N/A
- MDXG N/A
- Industry
- CCO Advertising
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- CCO Consumer Discretionary
- MDXG Health Care
- Exchange
- CCO Nasdaq
- MDXG Nasdaq
- Market Cap
- CCO 924.4M
- MDXG 1.0B
- IPO Year
- CCO 2005
- MDXG N/A
- Fundamental
- Price
- CCO $1.82
- MDXG $7.40
- Analyst Decision
- CCO Hold
- MDXG Buy
- Analyst Count
- CCO 5
- MDXG 1
- Target Price
- CCO $2.13
- MDXG $12.00
- AVG Volume (30 Days)
- CCO 4.3M
- MDXG 749.2K
- Earning Date
- CCO 11-06-2025
- MDXG 10-29-2025
- Dividend Yield
- CCO N/A
- MDXG N/A
- EPS Growth
- CCO N/A
- MDXG N/A
- EPS
- CCO 0.04
- MDXG 0.27
- Revenue
- CCO $1,538,895,000.00
- MDXG $393,442,000.00
- Revenue This Year
- CCO $6.16
- MDXG $12.68
- Revenue Next Year
- CCO $4.01
- MDXG $8.18
- P/E Ratio
- CCO $44.61
- MDXG $26.62
- Revenue Growth
- CCO 31.61
- MDXG 14.77
- 52 Week Low
- CCO $0.81
- MDXG $5.69
- 52 Week High
- CCO $2.03
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- CCO 68.20
- MDXG 68.68
- Support Level
- CCO $1.85
- MDXG $6.68
- Resistance Level
- CCO $2.03
- MDXG $6.86
- Average True Range (ATR)
- CCO 0.12
- MDXG 0.24
- MACD
- CCO 0.03
- MDXG 0.08
- Stochastic Oscillator
- CCO 86.64
- MDXG 90.27
About CCO Clear Channel Outdoor Holdings Inc.
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.